The DAK-Gesundheit is seeking suppliers to enter into a non-exclusive discount agreement for the medication containing the active ingredients Tafluprost and Timolol (ATC S01ED70). This agreement is in accordance with § 130a Abs. 8 SGB V, which allows health insurance companies and pharmaceutical com
243 days left to bid. Opened 1 year ago, deadline 5 Jul 2027.
Only 2 prior awards here — too little to read.
In healthcare medical, DAK HEALTH has awarded 2 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, NHS SUPPLY CHAIN COORDINATION LIMITED NHSSC SCCL — the field to beat, or your route in as a partner.
This contract opportunity involves the collection of used paper and the destruction of documents and data carriers across Germany. Suppliers are invited to provide services that include the secure destruction of paper, cardboard, and other materials. Detailed specifications of the required services
DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digital transformation in the German healthcare sector. This need arises from new legal requirements and the challenges posed by a volatile political environment and a shortage of skilled
This contract involves a non-exclusive discount agreement for the pharmaceutical substances Adapalene and Benzoyl Peroxide, classified under ATC code D10AD23. The agreement is established under Section 130a, Paragraph 8 of the German Social Code (SGB V), allowing health insurance funds and pharmaceu
DAK Health is seeking external support for the development of innovative IT solutions in response to the ongoing digitalization of the German healthcare system and related legal requirements. Due to the volatile political environment and the structural shortage of skilled IT professionals, DAK Healt
Ireland seeks to procure advanced gait training and therapy treadmill systems with sensor technology for outpatient rehabilitation services.
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
UCLH seeks a pharmacy provider to dispense medicines at hospital sites and deliver prescriptions to patients' homes while exploring opportunities for improved, cost-effective care.
Cornwall Council is testing the market for a digital stop smoking app to expand access to evidence-based cessation support beyond traditional service hours.
